PubMed · 8397764
Humanized antibodies.
Abstract
Hybridoma technology enabled rodent monoclonal antibodies to be created against human pathogens and cells, but these had limited clinical utility. Protein engineering is now generating antibodies for treatment of infectious disease, autoimmune disease and cancer by 'humanizing' rodent antibodies. Humanized antibodies have improved pharmacokinetics, reduced immunogenicity and have been used to clinical advantage.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
G Winter, W J Harris. 1993. Humanized antibodies.. https://doi.org/10.1016/0167-5699(93)90039-n. https://searchpubmed.org/record/pubmed%3A8397764/humanized-antibodies
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite Search PubMed by Indiciae: BibTeX · RIS.